Table 2.
The application of MSCs in other autoimmune diseases.
| Disease | Source of MSCs | Effects | Reference |
|---|---|---|---|
| T1D | UC-MSCs TGF-β/MSCs |
MSCs were safe and tolerable Hyperglycemia was significantly controlled |
[77, 86–89] |
| MS | BM-MSCs | Clinically feasible and relatively safe and could immediately produce immune regulation | [90–94] |
| SS | UC-MSCs | Effective in treatment | [95, 96] |
| PBC | BM-MSCs UC-MSCs |
MSCs were well tolerated and no obvious side effects were found Symptoms were significantly alleviated |
[97–99] |
| HT | AD-MSCs | MSCs inhibited inflammation and helped recover from injury | [79, 100, 101] |